Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27678454 | 0.88 | ALDH1A1 (0.40) | ALDH1A1MAPK1L3MBTL1SMN1; SMN2HIF1A | |
| Ammonia Solution, Strong SCHEMBL27691289 | 0.88 | ALDH1A1 (0.38) | ALDH1A1MAPK1L3MBTL1SMN1; SMN2HIF1A | |
| SCHEMBL1167642 | 0.86 | SMN1; SMN2 (0.46) | ALDH1A1MAPK1L3MBTL1SMN1; SMN2HIF1A | |
| SCHEMBL5711297 | 0.86 | GRM2 (0.48) | ALDH1A1MAPK1L3MBTL1SMN1; SMN2HIF1A | |
| SCHEMBL1167641 | 0.86 | SMN1; SMN2 (0.46) | ALDH1A1MAPK1L3MBTL1SMN1; SMN2HIF1A | |
| SCHEMBL7248792 | 0.86 | ALDH1A1 (0.49) | ALDH1A1MAPK1L3MBTL1EPHX2LMNA | |
| SCHEMBL27494515 | 0.85 | ALDH1A1 (0.47) | ALDH1A1MAPK1L3MBTL1EPHX2LMNA | |
| SCHEMBL27495686 | 0.85 | ALDH1A1 (0.47) | ALDH1A1MAPK1L3MBTL1EPHX2LMNA | |
| SCHEMBL27494516 | 0.85 | ALDH1A1 (0.47) | ALDH1A1MAPK1L3MBTL1EPHX2LMNA | |
| SCHEMBL10855143 | 0.85 | SMN1; SMN2 (0.47) | ALDH1A1MAPK1L3MBTL1SMN1; SMN2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | EPIX PHARMACEUTICALS, INC. | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213187-A1 | NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PGF, F13A1, F11 | ALDH1A1 4573/4885MAPK1 179/4885L3MBTL1 3482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.